{"id":"fibrin-pad","safety":{"commonSideEffects":[{"rate":null,"effect":"Infection at surgical site"},{"rate":null,"effect":"Seroma formation"},{"rate":null,"effect":"Allergic reaction"}]},"_chembl":{"chemblId":"CHEMBL2108390","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The pad consists of fibrinogen and thrombin that polymerize upon contact to create a stable fibrin clot, which adheres to bleeding surfaces and provides mechanical hemostasis. This allows for rapid control of bleeding during surgical procedures without requiring sutures or additional hemostatic measures. The fibrin matrix is gradually absorbed by the body as wound healing progresses.","oneSentence":"Fibrin Pad is a hemostatic agent that forms a fibrin clot matrix to promote rapid hemostasis and wound sealing at surgical sites.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:12:31.763Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hemostasis during surgical procedures"},{"name":"Control of bleeding in general, cardiac, and vascular surgery"}]},"trialDetails":[{"nctId":"NCT02090140","phase":"NA","title":"Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2015-11","conditions":"Degenerative Lesion of Articular Cartilage of Knee","enrollment":17},{"nctId":"NCT06220877","phase":"NA","title":"Efficacy of Buccal Pad of Fat, Advanced Platelet Rich Fibrin, Fibrin Glue and Oxidized Cellulose Plug in Management of Oro-Antral Communication, Comparative Clinical Study","status":"COMPLETED","sponsor":"October 6 University","startDate":"2019-01-01","conditions":"Healthy Volunteers Only","enrollment":24},{"nctId":"NCT04083807","phase":"PHASE3","title":"Efficacy and Safety of TISSEEL Lyo Compared to Manual Compression as an Adjunct to Haemostasis","status":"COMPLETED","sponsor":"Baxter Healthcare Corporation","startDate":"2019-07-10","conditions":"Adjunct to Hemostasis During Vascular Surgery","enrollment":104},{"nctId":"NCT04123860","phase":"PHASE4","title":"Effect of Buccal Fat Pad and Platelet Rich Fibrin After Ultrasonic Hydrodynamic Maxillary Sinus Membrane Elevation","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2019-11-10","conditions":"Maxillary Sinus","enrollment":12},{"nctId":"NCT01681030","phase":"PHASE2","title":"The Fibrin Pad Cardiovascular Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2012-08-01","conditions":"Cardiovascular Disease","enrollment":42},{"nctId":"NCT02040428","phase":"PHASE3","title":"The Fibrin Pad CV Phase III Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2014-01-01","conditions":"Cardiovascular Disease","enrollment":156},{"nctId":"NCT01662856","phase":"PHASE3","title":"Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery","status":"COMPLETED","sponsor":"Instituto Grifols, S.A.","startDate":"2012-08","conditions":"Vascular Surgical Bleeding","enrollment":225},{"nctId":"NCT01731938","phase":"PHASE3","title":"Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Soft Tissue Open Surgeries","status":"COMPLETED","sponsor":"Grifols Biologicals, LLC","startDate":"2012-11","conditions":"Soft Tissue Surgical Bleeding","enrollment":327},{"nctId":"NCT01754480","phase":"PHASE3","title":"Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries","status":"COMPLETED","sponsor":"Instituto Grifols, S.A.","startDate":"2013-03","conditions":"Parenchymous Tissue Surgical Bleeding","enrollment":325},{"nctId":"NCT00977925","phase":"PHASE3","title":"The Severe Soft Tissue Bleeding Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2009-08","conditions":"Soft Tissue Bleeding","enrollment":91},{"nctId":"NCT00658723","phase":"PHASE2","title":"The Fibrin Patch Soft Tissue Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2008-03","conditions":"Hemostasis","enrollment":141},{"nctId":"NCT01166243","phase":"PHASE3","title":"The Fibrin Pad Liver Study","status":"COMPLETED","sponsor":"Ethicon, Inc.","startDate":"2010-07","conditions":"Hemorrhage","enrollment":84},{"nctId":"NCT00892957","phase":"PHASE3","title":"FS VH S/D 500 S-apr in Vascular Surgery","status":"COMPLETED","sponsor":"Baxter Healthcare Corporation","startDate":"2009-07","conditions":"Hemostasis in Participants Receiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft Prostheses","enrollment":176},{"nctId":"NCT00576420","phase":"PHASE2","title":"Fibrin Sealant Vascular Surgery Study","status":"COMPLETED","sponsor":"Baxter Healthcare Corporation","startDate":"2007-12","conditions":"Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts)","enrollment":101}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Fibrin Pad","genericName":"Fibrin Pad","companyName":"Ethicon, Inc.","companyId":"ethicon-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fibrin Pad is a hemostatic agent that forms a fibrin clot matrix to promote rapid hemostasis and wound sealing at surgical sites. Used for Hemostasis during surgical procedures, Control of bleeding in general, cardiac, and vascular surgery.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}